BlackRock Fund Advisors - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 66 filers reported holding IMMUNE DESIGN CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q4 2016$2,441,000
-50.6%
443,790
-31.9%
0.00%
-100.0%
Q3 2016$4,940,000
+10.1%
651,726
+18.6%
0.00%0.0%
Q2 2016$4,486,000
-38.1%
549,736
-1.4%
0.00%
-50.0%
Q1 2016$7,247,000
-33.1%
557,427
+3.3%
0.00%0.0%
Q4 2015$10,837,000
+199.6%
539,686
+82.0%
0.00%
+100.0%
Q3 2015$3,617,000
-41.0%
296,469
-0.1%
0.00%0.0%
Q2 2015$6,130,000
+68.7%
296,851
+72.4%
0.00%0.0%
Q1 2015$3,634,000
-29.7%
172,152
+2.6%
0.00%0.0%
Q4 2014$5,167,000
+95.1%
167,869
+12.0%
0.00%0.0%
Q3 2014$2,648,000149,9380.00%
Other shareholders

There were no reported owners of IMMUNE DESIGN CORP in Q4 2016.

NameSharesValueWeighting ↓
View complete list of IMMUNE DESIGN CORP shareholders